News

PharmNovo appoints CFO and Clinical lead to strengthen the organization.

We are pleased to inform that during the summer, the application to start

We are pleased to announce that we have raised 67 MSEK in a new share issue led by Sciety.

The Clinical Trial Application (CTA) has been submitted to the MPA

It is with pleasure that we can announce that Clinical Trial Consultants AB (CTC)

We are pleased to announce that PharmNovo AB has been granted a patent for our candidate PN6047 in Canada. Previously patent has been granted in the USA, the EU, Japan, Australia and China. Canada was the last major country remaining for PN6047.